100 related articles for article (PubMed ID: 14729369)
1. The c-myc activation in cervical carcinomas and HPV 16 infections.
Abba MC; Laguens RM; Dulout FN; Golijow CD
Mutat Res; 2004 Feb; 557(2):151-8. PubMed ID: 14729369
[TBL] [Abstract][Full Text] [Related]
2. [The possibility of viral etiology in cervical carcinogenesis].
Iwasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):802-11. PubMed ID: 2172417
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection.
Zhang A; Månér S; Betz R; Angström T; Stendahl U; Bergman F; Zetterberg A; Wallin KL
Int J Cancer; 2002 Oct; 101(5):427-33. PubMed ID: 12216070
[TBL] [Abstract][Full Text] [Related]
4. Detection of human papillomavirus genome and analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinomas.
Iwasaka T; Yokoyama M; Oh-uchida M; Matsuo N; Hara K; Fukuyama K; Hachisuga T; Fukuda K; Sugimori H
Gynecol Oncol; 1992 Sep; 46(3):298-303. PubMed ID: 1326470
[TBL] [Abstract][Full Text] [Related]
5. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
6. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
[TBL] [Abstract][Full Text] [Related]
7. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes.
Tate JE; Mutter GL; Prasad CJ; Berkowitz R; Goodman H; Crum CP
Gynecol Oncol; 1994 Apr; 53(1):78-83. PubMed ID: 8175026
[TBL] [Abstract][Full Text] [Related]
8. Detection of human papillomavirus in organs of upper genital tract in women with cervical cancer.
Giordano G; D'Adda T; Gnetti L; Froio E; Merisio C; Melpignano M
Int J Gynecol Cancer; 2006; 16(4):1601-7. PubMed ID: 16884373
[TBL] [Abstract][Full Text] [Related]
9. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
10. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
11. Amplification of EGFR and cyclin D1 genes associated with human papillomavirus infection in oral squamous cell carcinoma.
Chuerduangphui J; Pientong C; Patarapadungkit N; Chotiyano A; Vatanasapt P; Kongyingyoes B; Promthet S; Swangphon P; Bumrungthai S; Pimson C; Ekalaksananan T
Med Oncol; 2017 Sep; 34(9):148. PubMed ID: 28741068
[TBL] [Abstract][Full Text] [Related]
12. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
Nagai N
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
[TBL] [Abstract][Full Text] [Related]
13. c-myc and c-Ha-ras cellular oncogenes and human papillomaviruses in benign and malignant cutaneous lesions.
Pelisson I; Soler C; Pechoux C; Chignol MC; Viac J; Euvrard S; Chardonnet Y
J Dermatol Sci; 1992 Jan; 3(1):56-67. PubMed ID: 1317208
[TBL] [Abstract][Full Text] [Related]
14. Association between activated K-ras and c-erbB-2 oncogenes with "high-risk" and "low-risk" human papilloma virus types in preinvasive cervical lesions.
Mourón SA; Abba MC; Güerci A; Gómez MA; Dulout FN; Golijow CD
Mutat Res; 2000 Aug; 469(1):127-34. PubMed ID: 10946249
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus DNA and oncogene alterations in colorectal tumors.
Pérez LO; Barbisan G; Ottino A; Pianzola H; Golijow CD
Pathol Oncol Res; 2010 Sep; 16(3):461-8. PubMed ID: 20232185
[TBL] [Abstract][Full Text] [Related]
16. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
[TBL] [Abstract][Full Text] [Related]
17. The role of p53 inactivation in human cervical cell carcinoma development.
Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human papillomavirus genotypes in women with normal and abnormal cervical cytology in Iran.
Ghaffari SR; Sabokbar T; Mollahajian H; Dastan J; Ramezanzadeh F; Ensani F; Yarandi F; Mousavi-Jarrahi A; Mohagheghi MA; Moradi A
Asian Pac J Cancer Prev; 2006; 7(4):529-32. PubMed ID: 17250423
[TBL] [Abstract][Full Text] [Related]
19. Nuclear proto-oncogene products transactivate the human papillomavirus type 16 promoter.
Nürnberg W; Artuc M; Vorbrueggen G; Kalkbrenner F; Moelling K; Czarnetzki BM; Schadendorf D
Br J Cancer; 1995 May; 71(5):1018-24. PubMed ID: 7734293
[TBL] [Abstract][Full Text] [Related]
20. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G
Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]